Literature DB >> 10696065

Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6 in the lung.

C Kuhn1, R J Homer, Z Zhu, N Ward, R A Flavell, G P Geba, J A Elias.   

Abstract

Understanding the sources of variation in airway reactivity and airflow is important for unraveling the pathophysiology of asthma, obstructive lung disease, and other pulmonary disorders. Transgenic expression of two closely related cytokines in the mouse lung produced opposite effects on these parameters. Interleukin (IL)-6 did not alter basal airways resistance and decreased methacholine responsiveness, whereas IL-11 caused airways obstruction and increased airway responses to methacholine. To clarify these differences we examined histologic sections and used morphometry to compare bronchiolar and parenchymal dimensions in 1- to 2-mo-old transgenic mice expressing IL-6 or IL-11 and littermate control mice. Both transgenic strains showed similar emphysema-like airspace enlargement, nodular peribronchiolar collections of mononuclear cells, thickening of airway walls, and subepithelial airway fibrosis. When compared with littermate control mice, the IL-6 mice showed an approximately 50% increase in the caliber of their bronchioles and an increase in airway wall thickness that was in proportion to the increase in the size of their airways. In contrast, the remodeling response was more robust in the IL-11 transgenic mice. It was also seen in airways with normal external and luminal diameters and thus was out of proportion to the caliber of their airways. These results support the hypothesis that structural alterations and resulting caliber changes of respiratory airways can have important effects on airway physiology and reactivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10696065     DOI: 10.1165/ajrcmb.22.3.3690

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  48 in total

1.  Overexpression of dominant negative peroxisome proliferator-activated receptor-γ (PPARγ) in alveolar type II epithelial cells causes inflammation and T-cell suppression in the lung.

Authors:  Lingyan Wu; Guixue Wang; Peng Qu; Cong Yan; Hong Du
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysema.

Authors:  R Mahadeva; S D Shapiro
Journal:  Thorax       Date:  2002-10       Impact factor: 9.139

3.  Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis.

Authors:  Cesar E Ochoa; Seyedeh Golsar Mirabolfathinejad; Venado Ana Ruiz; Scott E Evans; Mihai Gagea; Christopher M Evans; Burton F Dickey; Seyed Javad Moghaddam
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-22

4.  Analysis of Cell Turnover in the Bronchiolar Epithelium Through the Normal Aging Process.

Authors:  Marta Ortega-Martínez; Laura E Rodríguez-Flores; Adriana Ancer-Arellano; Ricardo M Cerda-Flores; Carlos de-la-Garza-González; Jesús Ancer-Rodríguez; Gilberto Jaramillo-Rangel
Journal:  Lung       Date:  2016-05-10       Impact factor: 2.584

Review 5.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

6.  IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.

Authors:  Mauricio S Caetano; Huiyuan Zhang; Amber M Cumpian; Lei Gong; Nese Unver; Edwin J Ostrin; Soudabeh Daliri; Seon Hee Chang; Cesar E Ochoa; Samir Hanash; Carmen Behrens; Ignacio I Wistuba; Cinthya Sternberg; Humam Kadara; Carlos Gil Ferreira; Stephanie S Watowich; Seyed Javad Moghaddam
Journal:  Cancer Res       Date:  2016-04-01       Impact factor: 12.701

7.  Elevation of IL-6 in the allergic asthmatic airway is independent of inflammation but associates with loss of central airway function.

Authors:  Wendy A Neveu; Jenna L Allard; Danielle M Raymond; Lorraine M Bourassa; Stephanie M Burns; Janice Y Bunn; Charles G Irvin; David A Kaminsky; Mercedes Rincon
Journal:  Respir Res       Date:  2010-03-08

8.  Associations of IL6 polymorphisms with lung function decline and COPD.

Authors:  J-Q He; M G Foreman; K Shumansky; X Zhang; L Akhabir; D D Sin; S F P Man; D L DeMeo; A A Litonjua; E K Silverman; J E Connett; N R Anthonisen; R A Wise; P D Paré; A J Sandford
Journal:  Thorax       Date:  2009-04-08       Impact factor: 9.139

Review 9.  Markers of early disease and prognosis in COPD.

Authors:  Morten Dahl; Børge G Nordestgaard
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15

10.  5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo.

Authors:  Tobias Müller; Thorsten Dürk; Britta Blumenthal; Melanie Grimm; Sanja Cicko; Elisabeth Panther; Stephan Sorichter; Yared Herouy; Francesco Di Virgilio; Davide Ferrari; Johannes Norgauer; Marco Idzko
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.